Travere Therapeutics Inc (TVTX)
5.725
-0.08
(-1.46%)
USD |
NASDAQ |
Apr 19, 16:00
5.73
0.00 (0.00%)
After-Hours: 19:14
Travere Therapeutics Free Cash Flow (Quarterly): -76.00M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -76.00M |
| September 30, 2023 | -64.69M |
| June 30, 2023 | -72.50M |
| March 31, 2023 | -109.08M |
| December 31, 2022 | -58.84M |
| September 30, 2022 | -47.31M |
| June 30, 2022 | -48.12M |
| March 31, 2022 | -60.59M |
| December 31, 2021 | -32.08M |
| September 30, 2021 | 26.69M |
| June 30, 2021 | 2.189M |
| March 31, 2021 | -35.74M |
| December 31, 2020 | -117.75M |
| September 30, 2020 | -0.18M |
| June 30, 2020 | -10.89M |
| March 31, 2020 | -33.77M |
| December 31, 2019 | -8.472M |
| September 30, 2019 | -18.34M |
| June 30, 2019 | -22.50M |
| March 31, 2019 | -24.47M |
| December 31, 2018 | -7.431M |
| September 30, 2018 | -7.744M |
| June 30, 2018 | -6.494M |
| March 31, 2018 | -22.99M |
| December 31, 2017 | -3.794M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.463M |
| June 30, 2017 | 2.447M |
| March 31, 2017 | -7.722M |
| December 31, 2016 | -12.72M |
| September 30, 2016 | 1.841M |
| June 30, 2016 | 1.684M |
| March 31, 2016 | -6.166M |
| December 31, 2015 | -5.276M |
| September 30, 2015 | -2.041M |
| June 30, 2015 | 6.465M |
| March 31, 2015 | -7.567M |
| December 31, 2014 | -9.176M |
| September 30, 2014 | -15.66M |
| June 30, 2014 | -14.95M |
| March 31, 2014 | -10.03M |
| December 31, 2013 | -13.67M |
| September 30, 2013 | -2.668M |
| June 30, 2013 | -2.217M |
| March 31, 2013 | -4.585M |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | 0.00 |
| August 31, 2011 | 0.00 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-117.75M
Minimum
Dec 2020
26.69M
Maximum
Sep 2021
-41.47M
Average
-35.74M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| AtriCure Inc | 1.244M |
| Bio-Rad Laboratories Inc | 38.80M |
| Artivion Inc | 8.911M |
| Shockwave Medical Inc | 63.58M |
| Perspective Therapeutics Inc | -9.097M |